U.S. Markets closed
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow 30

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • Russell 2000

    2,226.25
    -13.78 (-0.62%)
     
  • Crude Oil

    73.81
    +0.19 (+0.26%)
     
  • Gold

    1,816.90
    -18.90 (-1.03%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1872
    -0.0024 (-0.2018%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3908
    -0.0050 (-0.3547%)
     
  • USD/JPY

    109.6500
    +0.1890 (+0.1727%)
     
  • BTC-USD

    41,488.11
    +8.34 (+0.02%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Zevia Announces Pricing of Initial Public Offering

·3 min read

LOS ANGELES, July 22, 2021--(BUSINESS WIRE)--Zevia PBC (NYSE:ZVIA) today announced the pricing of its initial public offering of 10,700,000 shares of its Class A common stock at a public offering price of $14.00 per share. The shares are expected to begin trading on the New York Stock Exchange on July 22, 2021 under the ticker symbol "ZVIA."

In addition, Zevia has granted the underwriters a 30-day option to purchase up to an additional 1,605,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on or about July 26, 2021 subject to satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC, BofA Securities and Morgan Stanley are acting as lead book-running managers for the proposed offering. Stephens Inc., BMO Capital Markets and Wells Fargo Securities are acting as joint book-running managers. Telsey Advisory Group, Loop Capital Markets, Academy Securities, AmeriVet Securities and Ramirez & Co., Inc. are acting as co-managers.

A registration statement relating to the shares being sold was filed with the U.S. Securities and Exchange Commission and became effective on July 21, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor will there be any sale of any of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering may be made only by means of a prospectus. Copies of the final prospectus related to the offering may be obtained, when available, from:

Goldman Sachs & Co. LLC
Prospectus Department
200 West Street
New York, NY 10282
telephone: 1-866-471-2526
facsimile: 212-902-9316
or by emailing Prospectus-ny@ny.email.gs.com

BofA Securities
NC1-004-03-43
200 North College Street, 3rd Floor
Charlotte, NC 28255-0001
Attn: Prospectus Department
or via email: dg.prospectus_requests@bofa.com

Morgan Stanley & Co. LLC
Attn: Prospectus Department
180 Varick Street, 2nd Floor
New York, NY 10014

About Zevia

Zevia PBC, a Public Benefit Corporation, is a certified B Corp focused on addressing the global health challenges resulting from excess sugar consumption by offering a broad portfolio of zero sugar, zero calorie, naturally sweetened beverages. All Zevia beverages are made with a handful of simple, plant-based ingredients, contain no artificial sweeteners, and are Non-GMO Project verified, gluten-free, Kosher, vegan, zero sodium and free of added color. As of 2020, Zevia is distributed in more than 25,000 retail locations in the U.S. and Canada through a diverse network of major retailers in the food, drug, mass, natural and ecommerce channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210722005540/en/

Contacts

Stephanie Schonauer
Investors
714-313-7827
steph@zevia.com

Sarah Kissko Hersh
Media
646-283-8508
skisskohersh@percepture.com

Reed Anderson
ICR
646-277-1260
reed.anderson@icrinc.com